Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

319 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic Granulomatous Disease with the McLeod Phenotype: a French National Retrospective Case Series.
Lhomme F, Peyrard T, Babinet J, Abou-Chahla W, Durieu I, Moshous D, Neven B, Rohrlich PS, Albinni S, Amiranoff D, Dumont MD, Lortholary O, Héritier S, Marguet C, Suarez F, Fischer A, Blanche S, Hermine O, Mahlaoui N. Lhomme F, et al. Among authors: durieu i. J Clin Immunol. 2020 Jul;40(5):752-762. doi: 10.1007/s10875-020-00791-w. Epub 2020 Jun 19. J Clin Immunol. 2020. PMID: 32562208
Parental consanguinity is associated with a severe phenotype in common variable immunodeficiency.
Rivoisy C, Gérard L, Boutboul D, Malphettes M, Fieschi C, Durieu I, Tron F, Masseau A, Bordigoni P, Alric L, Haroche J, Hoarau C, Bérézné A, Carmagnat M, Mouillot G, Oksenhendler E; DEFI study group. Rivoisy C, et al. Among authors: durieu i. J Clin Immunol. 2012 Feb;32(1):98-105. doi: 10.1007/s10875-011-9604-9. Epub 2011 Oct 15. J Clin Immunol. 2012. PMID: 22002594
Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes.
Martel C, Mollin M, Beaumel S, Brion JP, Coutton C, Satre V, Vieville G, Callanan M, Lefebvre C, Salmon A, Pagnier A, Plantaz D, Bost-Bru C, Eitenschenck L, Durieu I, Floret D, Galambrun C, Chambost H, Michel G, Stephan JL, Hermine O, Blanche S, Blot N, Rubié H, Pouessel G, Drillon-Haus S, Conrad B, Posfay-Barbe KM, Havlicekova Z, Voskresenky-Baricic T, Jadranka K, Arriazu MC, Garcia LA, Sfaihi L, Bordigoni P, Stasia MJ. Martel C, et al. Among authors: durieu i. J Clin Immunol. 2012 Oct;32(5):942-58. doi: 10.1007/s10875-012-9698-8. Epub 2012 May 5. J Clin Immunol. 2012. PMID: 22562447
Thalidomide in systemic mastocytosis: results from an open-label, multicentre, phase II study.
Gruson B, Lortholary O, Canioni D, Chandesris O, Lanternier F, Bruneau J, Grosbois B, Livideanu C, Larroche C, Durieu I, Barete S, Sevestre H, Diouf M, Chaby G, Marolleau JP, Dubreuil P, Hermine O, Damaj G. Gruson B, et al. Among authors: durieu i. Br J Haematol. 2013 May;161(3):434-42. doi: 10.1111/bjh.12265. Epub 2013 Feb 22. Br J Haematol. 2013. PMID: 23432617 Free article. Clinical Trial.
Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.
Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, Godeberge P, Sokol H, Catherinot E, Poiree S, Chapdelaine H, Dunogue B, Bodemer C, Lecuit M, Fischer A, Lortholary O, Hermine O. Noel N, et al. Among authors: durieu i. J Allergy Clin Immunol. 2013 Oct;132(4):997-1000.e1-4. doi: 10.1016/j.jaci.2013.04.059. Epub 2013 Jun 20. J Allergy Clin Immunol. 2013. PMID: 23791514 No abstract available.
Leukocyte telomere length in mastocytosis: correlations with depression and perceived stress.
Georgin-Lavialle S, Moura DS, Bruneau J, Chauvet-Gélinier JC, Damaj G, Soucie E, Barete S, Gacon AL, Grandpeix-Guyodo C, Suarez F, Launay JM, Durieu I, Esparcieux A, Guichard I, Sparsa A, Nicolini F, Gennes Cd, Trojak B, Haffen E, Vandel P, Lortholary O, Dubreuil P, Bonin B, Sultan S, Teyssier JR, Hermine O. Georgin-Lavialle S, et al. Among authors: durieu i. Brain Behav Immun. 2014 Jan;35:51-7. doi: 10.1016/j.bbi.2013.07.009. Epub 2013 Aug 1. Brain Behav Immun. 2014. PMID: 23917070
ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
Damaj G, Joris M, Chandesris O, Hanssens K, Soucie E, Canioni D, Kolb B, Durieu I, Gyan E, Livideanu C, Chèze S, Diouf M, Garidi R, Georgin-Lavialle S, Asnafi V, Lhermitte L, Lavigne C, Launay D, Arock M, Lortholary O, Dubreuil P, Hermine O. Damaj G, et al. Among authors: durieu i. PLoS One. 2014 Jan 21;9(1):e85362. doi: 10.1371/journal.pone.0085362. eCollection 2014. PLoS One. 2014. PMID: 24465546 Free PMC article.
Association of mastocytosis with inflammatory joint diseases: a series of 31 patients.
Bader-Meunier B, Bulai Livideanu C, Larroche C, Durieu I, Artru L, Beucher A, Cormier G, Cornec D, Delarco M, Dubost JJ, Fontaine C, Gourin MP, Javier RM, de Jauréguiberry JP, Maisonneuve H, Toussirot E, Ugo V, Echaubard S, Mahlaoui N, Aouba A, Bodemer C, Briot K, Frenzel L, Lortholary O, Chandesris MO, Hermine O; CEREMAST, CRI and SOFREMIP. Bader-Meunier B, et al. Among authors: durieu i. Semin Arthritis Rheum. 2014 Dec;44(3):362-5. doi: 10.1016/j.semarthrit.2014.05.016. Epub 2014 Jun 17. Semin Arthritis Rheum. 2014. PMID: 25037281
Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients.
Lafont E, Lhermitte L, Damaj G, Soucie E, Barete S, Chandesris MO, Cabaret L, Guichard I, Durieu I, Retornaz F, Sarrot-Reynauld F, Hamidou M, Bruneau J, Aouba A, Dubreuil P, Lortholary O, Asnafi V, Hermine O, Georgin-Lavialle S. Lafont E, et al. Among authors: durieu i. Eur J Dermatol. 2015 Apr;25(2):182-4. doi: 10.1684/ejd.2014.2484. Eur J Dermatol. 2015. PMID: 25547160 No abstract available.
319 results